Error message

The page you requested does not exist. For your convenience, a search was performed using the query cbssm med umich edu people christian vercler md ma.

Page not found

You are here

CBSSM Seminar: Peter A Ubel, MD

Tue, April 10, 2018, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Peter A Ubel, MD

Professor of Business Administration
Madge and Dennis T. McLawhorn University Professor
Professor in the Sanford School of Public Policy
Professor of Medicine
Affiliate of the Duke Initiative for Science & Society
Member of the Duke Cancer Institute

“The Ethics of Nudges: An Informal Discussion”

This will be an informal discussion with Dr. Ubel, CBSSM faculty, and others to discuss their research around the ethics of nudges.

 

CBSSM Seminar: Darin Zahuranec, MD

Wed, January 20, 2016, 3:00pm to 4:00pm
Location: 
NCRC, Building 16, Room 266C

Darin Zahuranec, MD


Assistant Professor, Neurology

Title:  Improving decisions on life-sustaining treatments after stroke

Abstract:  Individuals with acute stroke face the sudden onset of new deficits, along with a need to make many decisions about medical treatments with impact on the potential for survival and long-term disability. This talk will review the challenges in decision-making after acute stroke and discuss possible solutions for the future.

 

Funded by the Alzheimer's Association

Active Year(s): 2008-2011

The goal of the MCI Risk Communication Study is to develop and evaluate a risk communication protocol to convey diagnostic and risk information to MCI patients and family members. A multi-step protocol will be created, taking into account principles of health risk communication, patient and provider preferences, and ethical issues involved in working with cognitively impaired populations. The protocol will be delivered by health care professionals with risk communication experience and tested on 10 patient/care-partner dyads recruited from Alzheimer’s Disease Centers at the University of Michigan and Boston University. The results of this pilot study will help inform the fourth trial of REVEAL.

PI: J. Scott Roberts, PhD

Tue, January 10, 2017

Jeffrey Kullgren was recently featured in the Michigan Medicine article, "What do health plan deductibles really mean for people with chronic illness? New study takes a look." Dr. Kullgren co-authored a JAMA Internal Medicine Research Letter, which reports that even “low” deductible plans can mean high out-of-pocket costs for many Americans.

Funded by the National Institutes of Health/Brigham and Women's Hospital/Boston University

Funding years: 2010-2013

The rapid identifcation of genetic risk factors for common, complex diseases poses great opportunities and challenges for public health. Genetic information is increasingly being utilized as part of commercial effors, including direct-to-consumer (DTC) genetic testing to provide risk information on common diseases to consumers. Very few empirical data have been gathered to understand the characteristics of DTC test consumers, the psychological, behavioral and health impact (clinical utility), and the ethical, legal and social issues associated with DTC services.

In the proposed research, we will survey users of the two leading US companies providing DTC genetic testing (23andMe and Navigenics) regarding their response to genetic test s for common diseases of interest, including heart disease, diabetes, Alzheimer's disease (AD), arthritis, and breast, colon, lung and prostate cancers. Each company now has thousands of customers and each anticipates extensive sales in coming years. Each has agreed to allow our group to survey consumers using third-party data collection and analysis procedures that will enable an independent consideration of the benefits and risks of DTC testing in this format. The companies have also agreed to provide genetic test information (with respondents' permission) for analyses. A total of 1000 consumers (500 from each company) website will be surveyed via the Internet at three time points: 1) before receipt of genetic test results; 2) approximately two weeks following receipt of test results; and 3) six months following receipt of results.

More information: http://www.psc.isr.umich.edu/research/project-detail/35031

PI: Scott Roberts

Co-I: Mick Couper

CBSSM Seminar: Julie Wright Nunes, MD, MPH

Wed, May 17, 2017, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Julie Wright Nunes, MD, MPH
Assistant Professor, Internal Medicine

Title: Patient Education and Care: Challenges and Opportunities in Chronic Kidney Disease

Abstract: Twenty million people, or 20% of U.S. adults ages 60 and older, have chronic kidney disease (CKD). CKD is a significant public health threat carrying high risk of morbidity, mortality, and renal failure. Health behavior theory suggests that patient motivation and healthy behavior change require patients to have knowledge of their chronic condition, as well as the self-efficacy and skills to do what is needed to stay healthy. The chronic care model promotes early patient engagement in care. Yet, less than 20% of  patients with CKD are aware of their diagnosis. Even patients who are aware often do not understand the implications of their CKD diagnosis or what they need to do to optimize their health. Dr. Wright Nunes will discuss her research aimed to develop, test, and disseminate sustainable patient-centric education and coaching support interventions to improve quality of care and outcomes in patients who have CKD.

The University of Michigan is seeking a nominee to the national competition for the Greenwall Foundation Faculty Scholars Program in Bioethics. The October 1st internal deadline has been extended. Details can be found at: http://orsp.umich.edu/funding/limited_submissions/greenwall.html.

Funded by Holden Research Fund Award

Funding Years: 2011

 

PI: Naomi Laventhal

Tue, March 13, 2018

CBSSM's Reshma Jagsi, Sarah Hawley and colleagues found that only half of women who could benefit from genetic testing get it, and often not before they have surgery. Steven Katz was lead author on this study.

CBSSM Seminar: Chithra Perumalswami, MD, MSc

Wed, May 23, 2018, 3:00pm
Location: 
NCRC, Building 10, Room G065

Chithra Perumalswami, MD, MSc
CBSSM Postdoctoral Fellow

 

Title:
Defining High Quality Health Care at the End of Life: Obesity in Hospice

Brief abstract:
Little is known about the challenges of providing high quality health care at the end of life for patients with obesity.  We conducted 22 semi-structured telephone interviews with hospice medical directors from each major geographic region of the US to understand physicians’ clinical and administrative perspectives regarding the effects of obesity on quality of hospice care for patients, caregivers, nurses, and other members of the hospice team.

 

Pages